The 5 analysts offering 12-month price forecasts for Pharming Group NV have a median target of 19.00, with a high estimate of 37.00 and a low estimate of 6.00. The median estimate represents a +46.29% increase from the last price of 12.99.
The current consensus among 5 polled investment analysts is to Buy stock in Pharming Group NV. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.06
Reporting Date Mar 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.